Partnership brings together Mahana’s expertise in digital therapeutic development with Bayer’s stated interest to deliver products that enable people to take greater control of their own personal health through world-leading digital solutions.
Mahana Therapeutics Signs Agreement with Consumer Health Division of Bayer to Commercialize DTx
Comments